Imedco Djaja is primarily engaged in pharmaceutical preparations, nec activity. Its headquarters is located in Dki Jakarta. The company was founded in 1966. Imedco Djaja is a prominent player in the Indonesian pharmaceutical industry, known for its commitment to quality and innovation in healthcare solutions. The company was founded by a group of visionary entrepreneurs who aimed to address the growing healthcare needs in Indonesia. Over the years, Imedco Djaja has expanded its operations to include a wide range of pharmaceutical products, focusing on both prescription and over-the-counter medications. The company operates several manufacturing facilities across Indonesia, ensuring a robust local presence and the ability to meet domestic demand efficiently. Imedco Djaja's product portfolio includes a variety of therapeutic categories, such as antibiotics, analgesics, and vitamins, under well-recognized brand names. In addition to its strong local footprint, Imedco Djaja has extended its reach to international markets, exporting its products to several countries in Southeast Asia and beyond. The company is actively involved in partnerships and collaborations with global pharmaceutical firms to enhance its research and development capabilities. Imedco Djaja is a member of several industry associations, which helps it stay at the forefront of pharmaceutical advancements and regulatory standards. The company is dedicated to improving public health and aims to be a leader in the pharmaceutical sector by continuously investing in innovative technologies and sustainable practices. With a vision to provide accessible and affordable healthcare solutions, Imedco Djaja is committed to enhancing the quality of life for people in Indonesia and around the world.
Headquarters
Green Lake City, Rukan Crown Blok B No. 28
West Jakarta; Jakarta;
Postal Code: 11750
Contact Details: Purchase the PT Imedco Djaja report to view the information.
Website: http://www.imedco-djaja.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service